N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

C87H84N38O9 — CID 160779058

IUPACN-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
SMILESCC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3cnn(CCO)c3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3n[nH]c(CO)n3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3noc(CO)n3)cn12.COCc1nc(-c2ccc3nnc(C(C)c4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)n[nH]1
InChIInChI=1S/C23H23N9O2.C22H22N10O2.C21H20N10O2.C21H19N9O3/c1-14(18-5-7-20-25-19(13-32(20)29-18)26-23(34)15-2-3-15)22-28-27-21-6-4-16(12-31(21)22)17-10-24-30(11-17)8-9-33;1-12(15-6-8-18-23-16(10-32(18)30-15)25-22(33)13-3-4-13)21-29-27-19-7-5-14(9-31(19)21)20-24-17(11-34-2)26-28-20;1-11(14-5-7-17-22-15(9-31(17)29-14)24-21(33)12-2-3-12)20-28-26-18-6-4-13(8-30(18)20)19-23-16(10-32)25-27-19;1-11(14-5-7-16-22-15(9-30(16)27-14)23-21(32)12-2-3-12)20-26-25-17-6-4-13(8-29(17)20)19-24-18(10-31)33-28-19/h4-7,10-15,33H,2-3,8-9H2,1H3,(H,26,34);5-10,12-13H,3-4,11H2,1-2H3,(H,25,33)(H,24,26,28);4-9,11-12,32H,2-3,10H2,1H3,(H,24,33)(H,23,25,27);4-9,11-12,31H,2-3,10H2,1H3,(H,23,32)
InChIKeySAIHNAYDSTYCGB-UHFFFAOYSA-N
MW1805.89 g/mol
LogP7.70
Rot. Bonds26

About N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide (PubChem CID 160779058) has the molecular formula C87H84N38O9 and a molecular weight of 1805.89 g/mol. Its IUPAC name is N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide.

Molecular Properties

Compound NameN-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
PubChem CID160779058
Molecular FormulaC87H84N38O9
Molecular Weight1805.89 g/mol
Exact Mass1804.73
IUPAC NameN-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
SMILESCC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3cnn(CCO)c3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3n[nH]c(CO)n3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3noc(CO)n3)cn12.COCc1nc(-c2ccc3nnc(C(C)c4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)n[nH]1
InChIInChI=1S/C23H23N9O2.C22H22N10O2.C21H20N10O2.C21H19N9O3/c1-14(18-5-7-20-25-19(13-32(20)29-18)26-23(34)15-2-3-15)22-28-27-21-6-4-16(12-31(21)22)17-10-24-30(11-17)8-9-33;1-12(15-6-8-18-23-16(10-32(18)30-15)25-22(33)13-3-4-13)21-29-27-19-7-5-14(9-31(19)21)20-24-17(11-34-2)26-28-20;1-11(14-5-7-17-22-15(9-31(17)29-14)24-21(33)12-2-3-12)20-28-26-18-6-4-13(8-30(18)20)19-23-16(10-32)25-27-19;1-11(14-5-7-16-22-15(9-30(16)27-14)23-21(32)12-2-3-12)20-26-25-17-6-4-13(8-29(17)20)19-24-18(10-31)33-28-19/h4-7,10-15,33H,2-3,8-9H2,1H3,(H,26,34);5-10,12-13H,3-4,11H2,1-2H3,(H,25,33)(H,24,26,28);4-9,11-12,32H,2-3,10H2,1H3,(H,24,33)(H,23,25,27);4-9,11-12,31H,2-3,10H2,1H3,(H,23,32)
InChIKeySAIHNAYDSTYCGB-UHFFFAOYSA-N
XLogP7.70
TPSA567.72 Ų
H-Bond Donors9
H-Bond Acceptors41
Rotatable Bonds26
Heavy Atoms134
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001805.89
LogP ≤ 57.70
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1041

Analyze N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233166
N-[6-[[6-[1-(2-hydroxyethyl)pyrazol-4-yl]benzotriazol-1-yl]methyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233038
N-[6-[2-imino-2-[5-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-2-methylidene-1-pyridinyl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 91278544
N-[6-[difluoro-[6-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233261
N-[6-[[6-[1-[(2S)-2,3-dihydroxypropyl]pyrazol-4-yl]benzotriazol-1-yl]methyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 46174264
3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]sulfanyl-N-(2-methylpropyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide
CID 59233137
3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]sulfanyl-N-(2-hydroxyethyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxamide
CID 59233152
N-[6-[(6-methoxy-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233255
N-[6-[[6-[1-[2-(dimethylamino)-2-oxoethyl]pyrazol-4-yl]benzotriazol-1-yl]methyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233239
N-[6-[(6-acetamido-[1,2,4]triazolo[4,3-a]pyridin-3-yl)sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[3-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]sulfanyl-[1,2,4]triazolo[4,3-a]pyridin-6-yl]cyclopropanecarboxamide;N-[6-[[6-(2-hydroxyethylcarbamoylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(3-hydroxypropanoylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[[6-(3-methoxypropanoylamino)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]sulfanyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 157424263
N-[6-[difluoro-[6-(3-propan-2-yloxyphenyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
CID 59233052
CID 159867427
CID 159867427

Frequently Asked Questions

What is the IUPAC name of N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The IUPAC name of N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide (CID 160779058) is N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide.
What is the SMILES notation for N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The canonical SMILES for N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide is CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3cnn(CCO)c3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3n[nH]c(CO)n3)cn12.CC(c1ccc2nc(NC(=O)C3CC3)cn2n1)c1nnc2ccc(-c3noc(CO)n3)cn12.COCc1nc(-c2ccc3nnc(C(C)c4ccc5nc(NC(=O)C6CC6)cn5n4)n3c2)n[nH]1.
What is the InChIKey of N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
The InChIKey is SAIHNAYDSTYCGB-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23N9O2.C22H22N10O2.C21H20N10O2.C21H19N9O3/c1-14(18-5-7-20-25-19(13-32(20)29-18)26-23(34)15-2-3-15)22-28-27-21-6-4-16(12-31(21)22)17-10-24-30(11-17)8-9-33;1-12(15-6-8-18-23-16(10-32(18)30-15)25-22(33)13-3-4-13)21-29-27-19-7-5-14(9-31(19)21)20-24-17(11-34-2)26-28-20;1-11(14-5-7-17-22-15(9-31(17)29-14)24-21(33)12-2-3-12)20-28-26-18-6-4-13(8-30(18)20)19-23-16(10-32)25-27-19;1-11(14-5-7-16-22-15(9-30(16)27-14)23-21(32)12-2-3-12)20-26-25-17-6-4-13(8-29(17)20)19-24-18(10-31)33-28-19/h4-7,10-15,33H,2-3,8-9H2,1H3,(H,26,34);5-10,12-13H,3-4,11H2,1-2H3,(H,25,33)(H,24,26,28);4-9,11-12,32H,2-3,10H2,1H3,(H,24,33)(H,23,25,27);4-9,11-12,31H,2-3,10H2,1H3,(H,23,32).
What are the key properties of N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide?
N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide has a molecular weight of 1805.89 g/mol, XLogP of 7.70, 26 rotatable bonds, 9 hydrogen bond donors, and 41 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[1-[6-[1-(2-hydroxyethyl)pyrazol-4-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1,2,4-oxadiazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(hydroxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide;N-[6-[1-[6-[5-(methoxymethyl)-1H-1,2,4-triazol-3-yl]-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide is sourced from PubChem (CID 160779058), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).